Literature DB >> 8515861

Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.

M L Vizuete1, V Steffen, A Ayala, J Cano, A Machado.   

Abstract

Rats were treated with deprenyl for 3 weeks. Afterwards, slices of the corpus striatum were incubated with 1-methyl-4-phenylpyridinium ion (MPP+). Concentrations of dopamine and its metabolite concentrations were assayed. The effect of MPP+ in animals treated with deprenyl was smaller than in controls, indicating that deprenyl protects against MPP+. We also measured superoxide dismutase (SOD) and catalase activities and carbonyl group content of the proteins. Both activities increased in deprenyl-treated rats, and the amount of carbonyl groups was unchanged. These results suggest that the protective effect of deprenyl is independent of the monoamine oxidase-B inhibitor and of the induction of SOD and catalase activities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515861     DOI: 10.1016/0304-3940(93)90496-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells.

Authors:  Yan Wang; Benjamin A Hilton; Kui Cui; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2015-06-03       Impact factor: 3.911

Review 2.  Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Authors:  Éva Szökő; Tamás Tábi; Peter Riederer; László Vécsei; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

3.  Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.

Authors:  R M Wu; D L Murphy; C C Chiueh
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl.

Authors:  C P de la Cruz; E Revilla; V Steffen; J A Rodríguez-Gómez; J Cano; A Machado
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.